565773 Sigma-Aldrichγ-Secretase Inhibitor XII - Calbiochem
γ-Secretase Inhibitor XII, is a cell-permeable, reversible inhibitor of γ-secretase activity in vitro (Aβ40 IC50 = 7.9 µM; Aβ42 IC50 = 7.6 µM) and in APP695 expressing CHO 2b-7 cells.
More>> γ-Secretase Inhibitor XII, is a cell-permeable, reversible inhibitor of γ-secretase activity in vitro (Aβ40 IC50 = 7.9 µM; Aβ42 IC50 = 7.6 µM) and in APP695 expressing CHO 2b-7 cells. Less<<Synonymes: Z-IL-CHO
Produits recommandés
Aperçu
Replacement Information |
---|
Tableau de caractéristiques principal
Empirical Formula |
---|
C₂₀H₃₀N₂O₄ |
Prix & Disponibilité
Référence | Disponibilité | Conditionnement | Qté | Prix | Quantité | |
---|---|---|---|---|---|---|
565773-5MG |
|
Ampoule plast. | 5 mg |
|
— |
References | |
---|---|
References | Weijzen, S., et al. 2002. Nat. Med. 8, 979. McLendon, C., et al. 2000. FASEB J. 14, 2383. |
Product Information | |
---|---|
ATP Competitive | N |
Form | White solid |
Hill Formula | C₂₀H₃₀N₂O₄ |
Chemical formula | C₂₀H₃₀N₂O₄ |
Reversible | Y |
Structure formula Image | |
Quality Level | MQ100 |
Biological Information | |
---|---|
Primary Target | Aβ40 in vitro |
Primary Target IC<sub>50</sub> | 7.9 µM for Aβ40; 7.6 µM for Aβ42 in vitro |
Purity | ≥95% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Peptide Sequence | Z-Ile-Leu-CHO |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Référence | GTIN |
565773-5MG | 04055977267860 |
Documentation
γ-Secretase Inhibitor XII - Calbiochem FDS
Titre |
---|
γ-Secretase Inhibitor XII - Calbiochem Certificats d'analyse
Titre | Numéro de lot |
---|---|
565773 |
Références bibliographiques
Aperçu de la référence bibliographique |
---|
Weijzen, S., et al. 2002. Nat. Med. 8, 979. McLendon, C., et al. 2000. FASEB J. 14, 2383. |